🇺🇸 FDA
Patent

US 10479996

Antisense antiviral compound and method for treating ss/RNA viral infection

granted A61PA61P31/12A61P31/14

Quick answer

US patent 10479996 (Antisense antiviral compound and method for treating ss/RNA viral infection) held by Sarepta Therapeutics, Inc. expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/12, A61P31/14